Trgovina Innoviva - INVA CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Pogoji trgovanja
| Razmik | - | ||||||||
|
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.030779% | ||||||||
|
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | -0.013666% | ||||||||
| Čas nočne pristojbine | 22:00 (UTC) | ||||||||
| Min. tržena količina | 1 | ||||||||
| Valuta | USD | ||||||||
| Kritje | 20% | ||||||||
| Borza | United States of America | ||||||||
| Provizija na trgovanje | 0% |
*Information provided by Capital.com
Ključni statistični podatki
| Predhodno. Zapri* | N/A |
| Odpri* | N/A |
| Enoletna sprememba* | N/A |
| Dnevni razpon* | N/A |
| Razpon 52 wk | 11.57-20.71 |
| Povprečni obseg (10 dni) | 607.28K |
| Povprečni obseg (3 meseci) | 12.32M |
| Tržna kapitalizacija | 904.39M |
| Razmerje P/E | 4.06 |
| Število delnic v obtoku | 69.78M |
| Prihodki | 373.22M |
| EPS | 3.19 |
| Dividenda (donosnost v %) | N/A |
| Beta | 0.55 |
| Datum naslednjega zaslužka | Feb 7, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
|---|
Innoviva Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Letni
- Četrtletno
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Skupni prihodki | 133.569 | 217.217 | 261.004 | 261.016 | 336.794 | 391.866 |
| Prihodki | 133.569 | 217.217 | 261.004 | 261.016 | 336.794 | 391.866 |
| Celotni odhodki iz poslovanja | 24.581 | 33.613 | 22.753 | 14.656 | 15.671 | 16.763 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 23.188 | 32.258 | 22.753 | 14.656 | 13.883 | 16.187 |
| Raziskave in razvoj | 1.393 | 1.355 | 0 | 0 | 1.788 | 0.576 |
| Prihodki iz poslovanja | 108.988 | 183.604 | 238.251 | 246.36 | 321.123 | 375.103 |
| Prihodki (odhodki) od obresti, neto Neoperativni | -51.834 | -42.29 | -22.294 | -13.12 | 33.47 | 73.799 |
| Drugo, neto | 2.382 | -7.042 | -5.702 | -0.345 | -0.348 | -3.626 |
| Čisti dobiček pred obdavčitvijo | 59.536 | 134.272 | 210.255 | 232.895 | 354.245 | 445.276 |
| Čisti dobiček po davkih | 59.536 | 134.272 | 406.328 | 190.993 | 293.814 | 368.837 |
| Čisti dobiček pred dodatnimi postavkami | 59.536 | 134.143 | 395.056 | 157.288 | 224.402 | 265.854 |
| Skupaj izredne postavke | 0 | 0 | 0 | |||
| Čisti dobiček | 59.536 | 134.143 | 395.056 | 157.288 | 224.402 | 265.854 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | 59.536 | 134.143 | 395.056 | 157.288 | 224.402 | 265.854 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | 59.536 | 134.143 | 395.056 | 157.288 | 224.402 | 265.854 |
| Popravljen čisti dobiček | 59.536 | 134.143 | 395.056 | 157.288 | 229.119 | 270.59 |
| Popravljene ponderirane povprečne delnice | 123.233 | 119.866 | 113.408 | 113.409 | 113.554 | 94.31 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | 0.48312 | 1.11911 | 3.48349 | 1.38691 | 2.01771 | 2.86915 |
| Popravljen normalizirani dobiček na enoto čistega dobička | 0.48312 | 1.11911 | 3.48349 | 1.38691 | 2.01771 | 2.86915 |
| Manjšinski delež | -0.129 | -11.272 | -33.705 | -69.412 | -102.983 | |
| Prilagoditev za redčenje | 4.717 | 4.736 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| Skupni prihodki | 85.518 | 100.806 | 97.862 | 107.68 | 90.059 |
| Prihodki | 85.518 | 100.806 | 97.862 | 107.68 | 90.059 |
| Celotni odhodki iz poslovanja | 6.035 | 4.266 | 3.309 | 3.153 | 32.992 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 5.986 | 4.228 | 2.86 | 3.113 | 6.492 |
| Raziskave in razvoj | 0.049 | 0.038 | 0.449 | 0.04 | 5.838 |
| Prihodki iz poslovanja | 79.483 | 96.54 | 94.553 | 104.527 | 57.067 |
| Prihodki (odhodki) od obresti, neto Neoperativni | 50.381 | 40.59 | 29.276 | -46.448 | -12.099 |
| Drugo, neto | -0.433 | -0.951 | -0.652 | -1.59 | -0.25 |
| Čisti dobiček pred obdavčitvijo | 129.431 | 136.179 | 123.177 | 56.489 | 44.718 |
| Čisti dobiček po davkih | 109.695 | 110.846 | 102.646 | 45.65 | 37.858 |
| Manjšinski delež | -15.572 | -21.898 | -30.208 | -35.305 | -22.085 |
| Čisti dobiček pred dodatnimi postavkami | 94.123 | 88.948 | 72.438 | 10.345 | 15.773 |
| Čisti dobiček | 94.123 | 88.948 | 72.438 | 10.345 | 15.773 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | 94.123 | 88.948 | 72.438 | 10.345 | 15.773 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | 94.123 | 88.948 | 72.438 | 10.345 | 15.773 |
| Prilagoditev za redčenje | 1.204 | 1.163 | 1.186 | 1.183 | 2.569 |
| Popravljen čisti dobiček | 95.327 | 90.111 | 73.624 | 11.528 | 18.342 |
| Popravljene ponderirane povprečne delnice | 113.624 | 100.639 | 81.699 | 81.632 | 93.73 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | 0.83897 | 0.89539 | 0.90116 | 0.14122 | 0.19569 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Popravljen normalizirani dobiček na enoto čistega dobička | 0.83897 | 0.89539 | 0.90116 | 0.14122 | 0.38231 |
| Nenavadni odhodki (prihodki) | 20.662 |
- Letni
- Četrtletno
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 198.046 | 200.369 | 199.043 | 431.234 | 342.058 | 313.673 |
| Denarna sredstva in kratkoročne naložbe | 150.433 | 129.075 | 114.908 | 350.845 | 246.487 | 201.525 |
| Denarna sredstva in ustrezniki | 118.016 | 73.336 | 62.417 | 278.096 | 246.487 | 201.525 |
| Kratkoročne naložbe | 32.417 | 55.739 | 52.491 | 72.749 | 0 | |
| Celotne terjatve, neto | 46.847 | 70.54 | 83.286 | 79.427 | 93.931 | 110.711 |
| Accounts Receivable - Trade, Net | 46.847 | 70.54 | 83.286 | 79.427 | 93.931 | 110.711 |
| Prepaid Expenses | 0.766 | 0.754 | 0.849 | 0.962 | 1.64 | 1.437 |
| Total Assets | 378.996 | 367.337 | 548.193 | 724.826 | 999.57 | 926.395 |
| Property/Plant/Equipment, Total - Net | 0.368 | 0.209 | 0.16 | 0.033 | 0.028 | 0.012 |
| Intangibles, Net | 180.545 | 166.722 | 152.899 | 139.076 | 125.253 | 111.43 |
| Other Long Term Assets, Total | 0.037 | 0.037 | 196.091 | 154.483 | 93.973 | 17.435 |
| Total Current Liabilities | 20.049 | 34.742 | 5.7 | 5.371 | 6.11 | 5.807 |
| Accounts Payable | 0.128 | 0.601 | 0.011 | 0.01 | 0.066 | 0.027 |
| Accrued Expenses | 11.284 | 9.141 | 5.689 | 5.361 | 6.044 | 5.78 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 7.752 | 25 | 0 | |||
| Other Current Liabilities, Total | 0.885 | 0 | ||||
| Total Liabilities | 731.987 | 610.196 | 394.61 | 411.331 | 459.658 | 511.652 |
| Total Long Term Debt | 708.341 | 574.362 | 382.855 | 377.12 | 385.517 | 394.653 |
| Long Term Debt | 708.341 | 574.362 | 382.855 | 377.12 | 385.517 | 394.653 |
| Other Liabilities, Total | 3.597 | 0.94 | 0.586 | 0.219 | 0.106 | 0 |
| Total Equity | -352.991 | -242.859 | 153.583 | 313.495 | 539.912 | 414.743 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 1.085 | 1.019 | 1.011 | 1.013 | 1.014 | 0.696 |
| Additional Paid-In Capital | 1282.08 | 1258.15 | 1256.27 | 1258.86 | 1260.9 | 1264.02 |
| Retained Earnings (Accumulated Deficit) | -1632.89 | -1498.75 | -1103.69 | -946.404 | -722.002 | -456.148 |
| Treasury Stock - Common | -3.263 | -3.263 | 0 | -393.829 | ||
| Other Equity, Total | 0.001 | -0.018 | -0.003 | 0.027 | 0 | |
| Total Liabilities & Shareholders’ Equity | 378.996 | 367.337 | 548.193 | 724.826 | 999.57 | 926.395 |
| Total Common Shares Outstanding | 108.435 | 101.896 | 101.098 | 101.288 | 101.392 | 69.5655 |
| Minority Interest | 0.152 | 5.469 | 28.621 | 67.925 | 111.192 | |
| Long Term Investments | 438.258 | 483.845 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 372.933 | 148.261 | 236.928 | 313.673 | 317.823 |
| Denarna sredstva in kratkoročne naložbe | 282.89 | 43.265 | 135.115 | 201.525 | 216.802 |
| Denarna sredstva in ustrezniki | 282.89 | 43.265 | 135.115 | 201.525 | 216.802 |
| Celotne terjatve, neto | 88.974 | 104.262 | 101.271 | 110.711 | 93.515 |
| Accounts Receivable - Trade, Net | 88.974 | 104.262 | 101.271 | 110.711 | 93.515 |
| Prepaid Expenses | 1.069 | 0.734 | 0.542 | 1.437 | 5.576 |
| Total Assets | 1088.29 | 789.15 | 887.239 | 926.395 | 1107.47 |
| Property/Plant/Equipment, Total - Net | 0.024 | 0.019 | 0.015 | 0.012 | 3.985 |
| Intangibles, Net | 121.797 | 118.341 | 114.885 | 111.43 | 212.974 |
| Long Term Investments | 519.325 | 473.677 | 507.116 | 483.845 | 544.437 |
| Other Long Term Assets, Total | 74.211 | 48.852 | 28.295 | 17.435 | 22.711 |
| Total Current Liabilities | 3.804 | 5.371 | 3.125 | 5.807 | 109.227 |
| Accounts Payable | 0.014 | 0.03 | 0.089 | 0.027 | 1.808 |
| Accrued Expenses | 3.79 | 5.341 | 3.036 | 5.78 | 11.403 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 453.829 | 459.37 | 484.428 | 511.652 | 720.832 |
| Total Long Term Debt | 387.728 | 389.989 | 392.295 | 394.653 | 442.731 |
| Long Term Debt | 387.728 | 389.989 | 392.295 | 394.653 | 442.731 |
| Minority Interest | 62.22 | 63.965 | 88.994 | 111.192 | 165.575 |
| Other Liabilities, Total | 0.077 | 0.045 | 0.014 | 0 | 3.299 |
| Total Equity | 634.461 | 329.78 | 402.811 | 414.743 | 386.642 |
| Common Stock | 1.014 | 0.695 | 0.695 | 0.696 | 0.696 |
| Additional Paid-In Capital | 1261.33 | 1261.84 | 1262.44 | 1264.02 | 1182.91 |
| Retained Earnings (Accumulated Deficit) | -627.879 | -538.931 | -466.493 | -456.148 | -403.137 |
| Total Liabilities & Shareholders’ Equity | 1088.29 | 789.15 | 887.239 | 926.395 | 1107.47 |
| Total Common Shares Outstanding | 101.408 | 69.495 | 69.492 | 69.5655 | 69.594 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
| Treasury Stock - Common | -393.829 | -393.829 | -393.829 | -393.829 | |
| Other Current Assets, Total | 1.93 | ||||
| Goodwill, Net | 5.544 | ||||
| Current Port. of LT Debt/Capital Leases | 96.016 |
- Letni
- Četrtletno
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Čisti prihodki/začetna postavka | 59.536 | 134.272 | 406.328 | 190.993 | 293.814 | 368.837 |
| Denarna sredstva iz poslovanja | 60.984 | 141.749 | 223.531 | 257.458 | 313.113 | 363.813 |
| Denarna sredstva iz poslovanja | 13.954 | 13.982 | 13.872 | 13.874 | 13.84 | 13.832 |
| Nedenarne postavke | 9.458 | 21.775 | 16.145 | 7.621 | -40.639 | -78.415 |
| Denarna sredstva Plačane obresti | 48.797 | 40.353 | 17.861 | 10.974 | 9.933 | 9.933 |
| Spremembe v obratnem kapitalu | -21.964 | -28.28 | -16.76 | 3.095 | -14.322 | -16.873 |
| Denarna sredstva pri naložbenju | -4.58 | -23.236 | 3.519 | -18.003 | -314.937 | 43.722 |
| Kapitalski izdatki | -0.278 | 0 | 0 | -0.012 | -0.013 | 0 |
| Celotne druge postavke denarnih tokov pri naložbenju | -4.302 | -23.236 | 3.519 | -17.991 | -314.924 | 43.722 |
| Denarna sredstva pri financiranju | -97.568 | -163.193 | -237.969 | -23.776 | -29.785 | -452.497 |
| Postavke denarnega toka pri financiranju | 0.578 | 0.023 | -5.955 | -10.553 | -30.129 | -59.457 |
| Total Cash Dividends Paid | -0.96 | -0.281 | -0.08 | -0.011 | 0 | 0 |
| Izdaja (odplačilo) delnic, neto | -78.788 | -99.193 | -1.934 | 0.538 | 0.344 | -393.04 |
| Izdaja (odplačilo) dolga, neto | -18.398 | -63.742 | -230 | -13.75 | 0 | 0 |
| Neto sprememba denarnih sredstev | -41.164 | -44.68 | -10.919 | 215.679 | -31.609 | -44.962 |
| Deferred Taxes | -196.054 | 41.875 | 60.42 | 76.432 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 109.695 | 220.541 | 323.187 | 368.837 | 37.858 |
| Cash From Operating Activities | 84.107 | 168.721 | 265.432 | 363.813 | 98.102 |
| Cash From Operating Activities | 3.46 | 6.918 | 10.376 | 13.832 | 3.501 |
| Deferred Taxes | 19.736 | 45.069 | 65.6 | 76.432 | 6.86 |
| Non-Cash Items | -52.003 | -93.637 | -124.495 | -78.415 | 31.684 |
| Cash Interest Paid | 4.967 | 4.967 | 9.933 | 9.933 | 5.411 |
| Changes in Working Capital | 3.219 | -10.17 | -9.236 | -16.873 | 18.199 |
| Cash From Investing Activities | -26.394 | 63.627 | 63.627 | 43.722 | -143.156 |
| Capital Expenditures | 0 | 0 | 0 | 0 | -0.009 |
| Other Investing Cash Flow Items, Total | -26.394 | 63.627 | 63.627 | 43.722 | -143.147 |
| Cash From Financing Activities | -21.31 | -435.57 | -440.431 | -452.497 | 60.331 |
| Financing Cash Flow Items | -21.285 | -41.446 | -46.358 | -59.457 | -6.507 |
| Issuance (Retirement) of Stock, Net | -0.025 | -394.124 | -394.073 | -393.04 | 0.214 |
| Net Change in Cash | 36.403 | -203.222 | -111.372 | -44.962 | 15.277 |
| Total Cash Dividends Paid | 0 | ||||
| Issuance (Retirement) of Debt, Net | 0 | 66.624 |
| Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
|---|---|---|---|---|---|---|
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 13.539 | 9447948 | 79542 | 2022-09-30 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 10.0125 | 6987044 | 27003 | 2022-09-30 | LOW |
| Sarissa Capital Management, L.P. | Hedge Fund | 9.4779 | 6614000 | 0 | 2022-09-30 | LOW |
| Putnam Investment Management, L.L.C. | Investment Advisor/Hedge Fund | 7.0958 | 4951669 | 1235940 | 2022-09-30 | LOW |
| Renaissance Technologies LLC | Hedge Fund | 6.1128 | 4265673 | -533300 | 2022-09-30 | HIGH |
| Westfield Capital Management Company, L.P. | Investment Advisor/Hedge Fund | 5.675 | 3960168 | 528481 | 2022-09-30 | LOW |
| Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 4.2075 | 2936119 | 237843 | 2022-09-30 | LOW |
| LSV Asset Management | Investment Advisor | 3.9575 | 2761703 | -449275 | 2022-09-30 | LOW |
| Millennium Management LLC | Hedge Fund | 3.5882 | 2503972 | 1178325 | 2022-09-30 | HIGH |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 3.5408 | 2470894 | 13786 | 2022-09-30 | LOW |
| Systematic Financial Management, L.P. | Investment Advisor | 2.6349 | 1838741 | 388755 | 2022-09-30 | LOW |
| Assenagon Asset Management S.A. | Investment Advisor | 2.4546 | 1712874 | -190058 | 2022-12-31 | HIGH |
| Pacer Advisors, Inc. | Investment Advisor | 2.1143 | 1475398 | 371034 | 2022-09-30 | HIGH |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.6479 | 1149935 | 14055 | 2022-09-30 | LOW |
| FundLogic SAS | Investment Advisor/Hedge Fund | 1.5189 | 1059944 | 0 | 2022-09-30 | HIGH |
| Goldman Sachs & Company, Inc. | Research Firm | 1.4152 | 987591 | 51769 | 2022-09-30 | MED |
| D. E. Shaw & Co., L.P. | Hedge Fund | 1.336 | 932321 | -221413 | 2022-09-30 | MED |
| Citadel Advisors LLC | Hedge Fund | 1.2008 | 837944 | 237602 | 2022-09-30 | HIGH |
| BofA Global Research (US) | Research Firm | 0.9691 | 676268 | -1238955 | 2022-09-30 | LOW |
| Nuveen LLC | Pension Fund | 0.8862 | 618444 | -346071 | 2022-09-30 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group +485000+
Borzni posredniki
65000+
Aktivne stranke mesečno
$48000000+
Mesečni obseg naložb
$28000000+
Preizkusi zdaj Dvigi vsak mesec
Kalkulator trgovanja
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trgovalna provizija
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Vzvod
20:1
- 20
- 100
- 500
- 1000
- 10000
Naložbe
Velikost posla (finančni vzvod x naložba):
Odpiranje
Zapiranje
Kratka Dolga
Innoviva Company profile
O družbi Innoviva
Innoviva, Inc. je podjetje s portfeljem licenčnin in drugih sredstev na področju zdravstva. V njenem portfelju licenčnin so sredstva za zdravljenje dihal, ki jih je pridobila v partnerstvu z družbo Glaxo Group Limited (GSK), in sicer RELVAR/BREO ELLIPTA (flutikazon furoat/vilanterol, FF/VI), ANORO ELLIPTA (umeklidinijev bromid/vilanterol, UMEC/VI) in TRELEGY ELLIPTA (kombinacija FF/UMEC/VI). V skladu s sporazumom o sodelovanju z dolgo delujočim agonistom beta2 (LABA) je družba Innoviva upravičena do prejemanja licenčnin od družbe GSK za prodajo zdravila RELVAR/BREO ELLIPTA in licenčnin od prodaje zdravil ANORO in ELLIPTA. RELVAR/BREO je kombinirano zdravilo, ki se uporablja enkrat na dan in je sestavljeno iz LABA, vilanterola (VI), in inhalacijskega kortikosteroida (ICS) ter flutikazon furoata (FF). ANORO ELLIPTA je zdravilo, ki se daje enkrat na dan in vsebuje dolgo delujoči muskarinski antagonist (LAMA), umeklidinijev bromid (UMEC), ter LABA, VI. TRELEGY ELLIPTA je kombinirano zdravilo, ki se daje enkrat na dan in vsebuje ICS, LAMA in LABA.
| Industry: | Pharmaceuticals (NEC) |
1350 Old Bayshore Highway
Suite 400
BURLINGAME
CALIFORNIA 94010
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 485.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com